Venography Market: Introduction
- Venography, also known as phlebography, is an X-ray examination that uses an injection filled with contrast media which shows the blood flowing through the veins. This enables specialists to identify blood clots in veins, use in bypass procedure, and in dialysis access or during surgery.
- This technique enables specialists to determine the condition of veins in patients and decide accurate & potential diagnosis
- Venography is considered a gold standard for diagnosis of deep vein thrombosis (DVT). The method is commonly used to show the level of reflux and degree of venous obstruction.
- Contrast venography is widely used as a diagnostic tool for acute or chronic thrombotic diseases, iliac vein compression syndrome, postthrombotic syndrome, and hemodynamic malfunction of the venous system
- Venography is considered a reference standard for diagnosis of venous thrombosis in the lower & upper extremities and allows quantification for venous occlusion and identification of collateral vessels
Key Drivers, Restraints, and Opportunities of Venography Market
- Venography provides an accurate visualization of the veins. This boosts demand for the procedure in the market. Venography shows the presence and location of occlusions. These factors are projected to drive the global venography market during the forecast period.
- Availability of venogram across hospitals, clinics, and other health care settings and faster adoption by physicians are anticipated to propel the global market in the next few years. Venography is considered a potential diagnostic tool for identifying health concerns. Venography procedure is invasively used for structural anatomy, vessel patency, and to understand flow traits of venous drainage, which augments demand for venography.
- However, in some patients, venography has shown higher risk and side effects including increase in allergic reactions, kidney injury and related impaired kidney functions, risk of developing contrast induced nephropathy, and damage to blood vessels, bleeding, or bruising. These factors are expected to restrain the global venography market during forecast period.
North America to Dominate Global Venography Market
- North America accounted for significant share of the global venography market in 2020, followed by Europe. Faster adoption of venography and its usage by physicians are likely to boost the growth of the market in the region during the forecast period. Venography is an accurate confirmatory test for the detection of DVT. Moreover, descending venography is used for the evaluation of the venous valves in lower extremities, which is projected to drive the venography market in North America.
- Europe was the second largest market for venography in 2020 owing to focus on preventative care and rise in demand for precision diagnostics. Furthermore, expansion of application of venography in veterinary treatment propels the market in the region during the forecast period.
Key Companies in Global Venography Market
- AccuVein
- Bruker
- Carestream Health
- Canon Medical Systems Corporation
- FUJIFILM Holdings Corporation
- General Electric Company
- Hologic, Inc.
- Hitachi, Ltd.
- Koninklijke Philips N.V.
- Medonica Co. Ltd.
- Neusoft Corporation
- Shimadzu Corporation
- Siemens Medical Solutions USA, Inc.
- Vuetek Scientific
- Time Medical Holdings Company Limited
- Other prominent players
Global Venography Market, Research Scope
Global Venography Market, by Type
- Ascending Venography
- Descending Venography
- Upper Extremity Venography
- Venacavography
Global Venography Market, by End-user
- Hospitals
- Clinics
- Diagnostic Imaging Centers
- Ambulatory Surgical Centers
Global Venography Market, by Region
- North America
- Europe
- Germany
- France
- U.K.
- Italy
- Spain
- Rest of Europe
- Asia Pacific
- China
- Japan
- India
- Australia & New Zealand
- Rest of Asia Pacific
- Latin America
- Brazil
- Mexico
- Rest of Latin America
- Middle East & Africa
- GCC Countries
- South Africa
- Rest of Middle East & Africa